EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Regional News

Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO

Argenx is off to the races with the launch of its new med Vyvgart. With its first FDA-approved drug Vyvgart now rolling out, Argenx is charting a course to become an...
Continue Reading →
Quotient